NasdaqGS - Nasdaq Real Time Price USD

Amylyx Pharmaceuticals, Inc. (AMLX)

Compare
3.5000
-0.2700
(-7.16%)
At close: January 10 at 4:00:01 PM EST
3.4617
-0.04
(-1.09%)
After hours: January 10 at 4:11:03 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
517,454.0000
391,453.0000
105,614.0000
14,104.0000
Total Liabilities Net Minority Interest
84,022.0000
50,846.0000
256,782.0000
80,829.0000
Total Equity Gross Minority Interest
433,432.0000
340,607.0000
-151,168.0000
-66,725.0000
Total Capitalization
433,432.0000
340,607.0000
-151,168.0000
-65,300.0000
Common Stock Equity
433,432.0000
340,607.0000
-151,168.0000
-66,725.0000
Capital Lease Obligations
4,237.0000
6,277.0000
--
--
Net Tangible Assets
433,432.0000
340,607.0000
-151,168.0000
-66,725.0000
Working Capital
382,624.0000
335,524.0000
87,555.0000
6,313.0000
Invested Capital
433,432.0000
340,607.0000
-151,168.0000
-65,300.0000
Tangible Book Value
433,432.0000
340,607.0000
-151,168.0000
-66,725.0000
Total Debt
4,237.0000
6,277.0000
--
1,425.0000
Share Issued
67,707.4320
66,512.0110
55,216.0130
55,216.0130
Ordinary Shares Number
67,707.4320
66,512.0110
55,216.0130
55,216.0130
12/31/2020 - 1/7/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers